InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.8686
+0.0261 (3.09%)
Sep 4, 2026, 11:37 AM EDT - Market open
InspireMD Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, InspireMD stock has a consensus rating of "Buy" and an average price target of $3.33. The average 1-year stock price forecast is 283.38% higher than the current stock price, while the lowest is $3.00 (+245.38%) and the highest is $4.00 (+360.51%).
Price Target: $3.33 (+283.38%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for InspireMD stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +245.38% | Aug 19, 2026 |
| Lake Street | Lake Street | Buy Reiterates $4 | Buy | Reiterates | $4 | +360.51% | Aug 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $3 | Buy | Maintains | $3 | +245.38% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
9.80M
from 8.98M
Increased by 9.14%
Revenue Next Year
20.13M
from 9.80M
Increased by 105.44%
EPS This Year
-0.45
from -0.76
EPS Next Year
-0.48
from -0.45
EPS and Forward PE are based on non-GAAP adjusted numbers.